I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis
    81.
    发明申请
    I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis 审中-公开
    I-FLICE,一种新型的肿瘤坏死因子受体-1抑制剂和CD-95诱导的细胞凋亡

    公开(公告)号:US20060240036A1

    公开(公告)日:2006-10-26

    申请号:US11445311

    申请日:2006-06-02

    CPC分类号: C12N9/6475 A61K38/00

    摘要: The present invention relates to a novel I-FLICE-1 or I-FLICE-2 protein which is a novel inhibitor of TNFR-1 and CD-95 induced apoptosis. In particular, isolated nucleic acid molecules are provided encoding the human I-FLICE-1 or I-FLICE-2 protein. I-FLICE-1 or I-FLICE-2 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of I-FLICE-1 or I-FLICE-2 activity. Also provided are therapeutic methods for treating diseases and disorders associated with apoptosis.

    摘要翻译: 本发明涉及一种新型的I-FLICE-1或I-FLICE-2蛋白,其是TNFR-1和CD-95诱导的细胞凋亡的新型抑制剂。 特别地,提供编码人I-FLICE-1或I-FLICE-2蛋白的分离的核酸分子。 还提供I-FLICE-1或I-FLICE-2多肽,载体,宿主细胞和用于制备它的重组方法。 本发明还涉及用于鉴定I-FLICE-1或I-FLICE-2活性的激动剂和拮抗剂的筛选方法。 还提供了用于治疗与凋亡相关的疾病和病症的治疗方法。

    Death domain containing receptor 4
    83.
    发明申请
    Death domain containing receptor 4 有权
    死亡域含受体4

    公开(公告)号:US20050112090A9

    公开(公告)日:2005-05-26

    申请号:US10648786

    申请日:2003-08-27

    摘要: The present invention relates to novel Death Domain Containing Receptor-4 (DR4) proteins which are members of the tumor necrosis factor (TNF) receptor family. In particular, isolated nucleic acid molecules are provided encoding the human DR4 proteins. DR4 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of DR4 activity and methods for using DR4 polynucleotides and polypeptides. The invention also relates to the treatment of diseases associated with reduced or increased levels of apoptosis using antibodies specific for DR4, which may be agonists and/or antagonists of DR4 activity.

    摘要翻译: 本发明涉及作为肿瘤坏死因子(TNF)受体家族成员的新的含有死亡域的受体-4(DR4)蛋白。 特别地,提供编码人DR4蛋白的分离的核酸分子。 还提供了DR4多肽,载体,宿主细胞和用于制备它们的重组方法。 本发明还涉及用于鉴定DR4活性的激动剂和拮抗剂的筛选方法以及使用DR4多核苷酸和多肽的方法。 本发明还涉及使用DR4特异性抗体(其可以是DR4活性的激动剂和/或拮抗剂)的减少或增加的细胞凋亡相关疾病的治疗。

    99 human secreted proteins
    87.
    发明申请
    99 human secreted proteins 审中-公开
    99人分泌蛋白

    公开(公告)号:US20070015162A1

    公开(公告)日:2007-01-18

    申请号:US10670185

    申请日:2003-09-25

    IPC分类号: C12Q1/68 C07H21/04 C12N5/06

    摘要: The present invention relates to human secreted polypeptides, and isolated nucleic acid molecules encoding said polypeptides, useful for diagnosing and treating allergic and asthmatic disorders. Antibodies that bind these polypeptides are also encompassed by the present invention. Also encompassed by the invention are vectors, host cells, and recombinant and synthetic methods for producing said polynucleotides, polypeptides, and/or antibodies. The invention further encompasses screening methods for identifying agonists and antagonists of polynucleotides and polypeptides of the invention. The present invention further encompasses methods and compositions for inhibiting or enhancing the production and function of the polypeptides of the present invention.

    摘要翻译: 本发明涉及人分泌多肽,以及编码所述多肽的分离的核酸分子,其可用于诊断和治疗过敏性和哮喘性疾病。 结合这些多肽的抗体也包括在本发明中。 本发明还包括载体,宿主细胞以及用于产生所述多核苷酸,多肽和/或抗体的重组和合成方法。 本发明还包括用于鉴定本发明的多核苷酸和多肽的激动剂和拮抗剂的筛选方法。 本发明还包括用于抑制或增强本发明多肽的产生和功能的方法和组合物。

    337 human secreted proteins
    88.
    发明申请
    337 human secreted proteins 审中-公开
    337人分泌蛋白

    公开(公告)号:US20060246483A1

    公开(公告)日:2006-11-02

    申请号:US11366486

    申请日:2006-03-03

    CPC分类号: C07K14/47

    摘要: The present invention relates to human secreted polypeptides, and isolated nucleic acid molecules encoding said polypeptides, useful for diagnosing and treating cardiovascular diseases, disorders, and/or conditions related thereto. Antibodies that bind these polypeptides are also encompassed by the present invention. Also encompassed by the invention are vectors, host cells, and recombinant and synthetic methods for producing said polynucleotides, polypeptides, and/or antibodies. The invention further encompasses screening methods for identifying agonists and antagonists of polynucleotides and polypeptides of the invention. The present invention further encompasses methods and compositions for inhibiting or enhancing the production and function of the polypeptides of the present invention.

    摘要翻译: 本发明涉及人分泌的多肽,以及编码所述多肽的分离的核酸分子,其可用于诊断和治疗与之有关的心血管疾病,病症和/或病症。 结合这些多肽的抗体也包括在本发明中。 本发明还包括载体,宿主细胞,以及用于产生所述多核苷酸,多肽和/或抗体的重组和合成方法。 本发明还包括用于鉴定本发明的多核苷酸和多肽的激动剂和拮抗剂的筛选方法。 本发明还包括用于抑制或增强本发明多肽的产生和功能的方法和组合物。

    Human secreted proteins
    90.
    发明申请
    Human secreted proteins 审中-公开
    人体分泌的蛋白质

    公开(公告)号:US20050197285A1

    公开(公告)日:2005-09-08

    申请号:US10472533

    申请日:2002-03-19

    摘要: The present invention relates to human secreted polypeptides, and isolated nucleic acid molecules encoding said polypeptides, useful for diagnosing and treating gastrointestinal diseases, disorders, and/or conditions related thereto. Antibodies that bind these polypeptides and also encompassed by the present invention. Also encompassed by the invention are vectors, host cells, and recombinant and synthetic methods for producing said polynucleotides, polypeptides, and/or antibodies. The invention further encompasses screening methods for identifying agonists and antogonists of polynucleotides and polypeptides of the invention. The present invention further encompasses methods and compositions for inhibiting or enhancing the production and function of the polypeptides of the present invention.

    摘要翻译: 本发明涉及人分泌多肽和编码所述多肽的分离的核酸分子,其可用于诊断和治疗与其有关的胃肠道疾病,病症和/或病症。 结合这些多肽并且也包括在本发明中的抗体。 本发明还包括载体,宿主细胞,以及用于产生所述多核苷酸,多肽和/或抗体的重组和合成方法。 本发明进一步包括用于鉴定本发明的多核苷酸和多肽的激动剂和亲和体的筛选方法。 本发明还包括用于抑制或增强本发明多肽的产生和功能的方法和组合物。